Journal of Addiction Research(JAR)
ISSN: 2573-9514 | DOI: 10.33140
Impact Factor: 1.62
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
Opioid Overdose Reversal with Naloxone (Narcan, Evzio)
Naloxone is a medication approved by the Food and Drug Administration (FDA) designed to rapidly reverse opioid overdose. It is an opioid antagonist- meaning that it binds to opioid receptors and can reverse and block the effects of other opioids, such as heroin, morphine, and oxycodone.Journal key Highlights
Abnormal Psychology
Addiction
Addiction Psychiatry
Addiction Recovery
Addictive Drug
Adolescent Addiction
Adolescent Anxiety
Alcohol Abuse
Alcohol Addiction Treatment
Alcohol Drinking
Alcohol Rehabilitation
Alcoholism
Alzheimers Symptoms
Amphetamine Addiction
Analytical Psychology
Anxiety Disorders
Autism
Behavioral Addiction
Biochemical Metabolism
Biological Psychiatry
Bipolar Psychosis
Brain Disorders
Caffeine
Cocaine Addiction
Cognitive Disorders
Community Psychiatry
Comorbidity
Cytochrome 450 Drug Metabolism
Depression Disorders
Drug Dependence
Drug Rehabilitation
Drug Therapy
Drug Tolerance
Drug Use Disorders
Gambling
Health Consequences of Drug Misuse
Hepatitis (Viral)
Heroin Addiction Treatment
Illegal Drugs
Insomnia
Legal Drugs
Mental and Behavioral Disorders
Morphine Addiction
Narcotics
Neurocognitive Disorders
Neuropsychological Disorder
Nicotine
Opioid Overdose Reversal with Naloxone (Narcan, Evzio)
Opioid-Related Disorders
Post Traumatic Disorders
Prevention
Recovery
Smoking
Study of Addiction
Substance Abuse in Military Life
Substance Use and SUDs in LGBT Populations
Substance-Related Disorders
Tobacco Use Disorder
Trauma
Traumatic Stress
Treatment
Veterinary Epidemiology
Women and Drugs
Yoga psychotherapy